Patrick Henn, MD
Assistant Professor, Pathology

Publications

• Wald A, Pingpank J, …Henn P, Singhi A, et al. Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms. Research Square; 2022. DOI: 10.21203/rs.3.rs-1821239/v1.
• Das R, McGrath K, Seiser N, Smith K, Uttam S, Brand RE, Fasanella KE, Khalid A, Chennat JS, Sarkaria S, Singh H, Slivka A, Zeh HJ, Zureikat AH, Hogg ME, Lee KK, Paniccia A, Ongchin MC, Pingpank JF, Boone BA, Dasyam AK, Bahary N, Gorantla VC, Rhee JC, Thomas R, Ellsworth S, Landau MS, Ohori NP, Henn P, Shyu S, Theisen BK, Singhi AD. Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome. Clin Gastroenterol Hepatol. 2022 Apr;20(4):886-897. PubMed PMID: 33278573
• Westbrook LM, Henn PA, Cornish TC. Lifting Agent Granuloma. Am J Clin Pathol. 2020 Apr 15;153(5):630-638. PubMed PMID: 31875886
• Das R, McGrath K, Seiser N, Smith K, Uttam S, Brand RE, Fasanella KE, Khalid A, Chennat JS, Sarkaria S, Singh H, Slivka A, Zeh HJ, Zureikat AH, Hogg ME, Lee K, Paniccia A, Ongchin MC, Pingpank JF, Boone BA, Dasyam AK, Bahary N, Gorantla VC, Rhee JC, Thomas R, Ellsworth S, Landau MS, Ohori NP, Henn P, Shyu S, Theisen BK, Singhi AD. Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome. Clin Gastroenterol Hepatol. 2020 Dec 2. [Epub ahead of print] PubMed PMID: 33278573
• Ma C, Henn P, Miller C, Herbst C, Hartman DJ, Pai RK. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma. Am J Surg Pathol. 2019 Oct;43(10):1314-1322. PubMed PMID: 31318711